Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
UTMD 
Utah Medical Products Inc (UTMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: UTMD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -29.62% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 187.75M USD | Price to earnings Ratio 15.25 | 1Y Target Price - |
Price to earnings Ratio 15.25 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.28 | 52 Weeks Range 50.98 - 75.79 | Updated Date 06/29/2025 |
52 Weeks Range 50.98 - 75.79 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 2.11% | Basic EPS (TTM) 3.79 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 33% | Operating Margin (TTM) 35.71% |
Management Effectiveness
Return on Assets (TTM) 7.06% | Return on Equity (TTM) 10.59% |
Valuation
Trailing PE 15.25 | Forward PE - | Enterprise Value 104398199 | Price to Sales(TTM) 4.78 |
Enterprise Value 104398199 | Price to Sales(TTM) 4.78 | ||
Enterprise Value to Revenue 2.66 | Enterprise Value to EBITDA 6.82 | Shares Outstanding 3248210 | Shares Floating 2801744 |
Shares Outstanding 3248210 | Shares Floating 2801744 | ||
Percent Insiders 7.04 | Percent Institutions 70.75 |
Upturn AI SWOT
Utah Medical Products Inc
Company Overview
History and Background
Utah Medical Products, Inc. was founded in 1978. The company develops, manufactures, and markets a broad range of disposable and reusable medical devices.
Core Business Areas
- Labor & Delivery: Devices for monitoring and facilitating childbirth, including fetal monitoring systems and vacuum delivery systems.
- Electrophysiology: Catheters and accessories used in cardiac electrophysiology procedures.
- Infusion Therapy: Devices for precise drug delivery.
- Gynecology/Urology: Products for female health, including uterine manipulators and urinary catheters.
Leadership and Structure
Kevin Cornwell is the President and CEO. The company has a traditional corporate structure with departments such as R&D, Manufacturing, Sales, and Marketing.
Top Products and Market Share
Key Offerings
- LEEP/LLETZ Electrode: Loop Electrosurgical Excision Procedure (LEEP) and Large Loop Excision of the Transformation Zone (LLETZ) electrodes used for gynecological procedures. Market share data is difficult to obtain precisely. Competitors include CooperSurgical, Bovie Medical (now part of Symmetry Surgical).
- Vacuum Delivery System: Devices aiding in childbirth, often used when labor is prolonged or complicated. Market share data is difficult to obtain precisely. Competitors include CooperSurgical, Kiwi Medical Technologies.
- Fetal Monitoring Accessories: Single-use devices for monitoring fetal heart rate and uterine contractions. Market share data is difficult to obtain precisely. Competitors include GE Healthcare, Philips Healthcare.
Market Dynamics
Industry Overview
The medical device industry is characterized by innovation, regulation, and competition. Trends include minimally invasive procedures, telehealth, and personalized medicine.
Positioning
Utah Medical Products, Inc. is a niche player focusing on specialized medical devices. Its competitive advantages include established product lines, strong relationships with healthcare professionals, and a reputation for quality.
Total Addressable Market (TAM)
The specific TAM for each product category varies significantly. Utah Medical's position within its TAM is strong in specific niches, but faces strong competition from larger players in other categories.
Upturn SWOT Analysis
Strengths
- Established product lines
- Strong relationships with healthcare professionals
- Reputation for quality
- Consistent Profitability
- Specialized niche focus
Weaknesses
- Relatively small size compared to major competitors
- Limited marketing resources
- Dependence on niche markets
- Lower growth rate than average
Opportunities
- Expanding into new geographic markets
- Developing innovative medical devices
- Acquiring complementary businesses
- Capitalizing on trends in minimally invasive procedures
Threats
- Increasing competition from larger medical device companies
- Changes in healthcare regulations
- Product liability lawsuits
- Economic downturns impacting hospital budgets
Competitors and Market Share
Key Competitors
- COOP
- SYK
- BSX
Competitive Landscape
Utah Medical Products competes with larger companies with greater resources. They maintain a competitive advantage through specialization and quality, but must continue innovating and expanding its reach.
Growth Trajectory and Initiatives
Historical Growth: Historical revenue growth has been modest, primarily driven by organic growth and price increases.
Future Projections: Analyst estimates suggest continued modest growth, driven by new product launches and geographic expansion.
Recent Initiatives: Recent initiatives include expanding international sales efforts and investing in R&D for new product development.
Summary
Utah Medical Products is a profitable company with a strong balance sheet and consistent dividend payouts. Its niche focus and established product lines provide a competitive advantage, but its smaller size relative to competitors poses a challenge. Maintaining innovation and exploring strategic acquisitions will be crucial for sustained growth. While profitable, revenue growth has been muted and will need to be addressed for increased valuations.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Company Website
- Market Research Reports
- Analyst Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share data is based on available estimates and may not be precise. Financial data is based on past performance and is not indicative of future results. Investing in stock market involves risk of loss of capital.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Utah Medical Products Inc
Exchange NASDAQ | Headquaters Midvale, UT, United States | ||
IPO Launch date 1999-03-08 | Chairman, CEO, President & Secretary Mr. Kevin L. Cornwell | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 155 | Website https://www.utahmed.com |
Full time employees 155 | Website https://www.utahmed.com | ||
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. The company serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.